Rockefeller Capital Management
BVS icon

Rockefeller Capital Management’s Bioventus BVS Stock Holding History

Rockefeller Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-163
Closed – – 2241
2022
Q4 		$0 Hold
163
– – ﹤0.01% 3871
2022
Q3 		$1K Buy
+163
New +$1.28K ﹤0.01% 3675

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Rockefeller Capital Management's BVS Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Bioventus (BVS) in Q1 2023, closing a stake of 163 shares.

Rockefeller Capital Management first reported a position in BVS in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 71 funds tracked by Wall St. Rank hold BVS as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Bioventus position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 163 Bioventus shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in Bioventus in Q3 2022 and held it in 2 quarters.
  • Rockefeller Capital Management's Bioventus position peaked at $1K in Q3 2022.
  • 71 funds tracked by Wall St. Rank held Bioventus as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.